Page 1 of Clinical Trials for Gardasil, 102 Total Matches

Show/Hide Clinical Trials Which are Not Seeking New Volunteers

1
Recruiting
A Clinical Trial to Study the Safety, Tolerance and Immunogenic Response to Gardasil and rLP2086 Vaccine When Given at the Same Time to Children Between the Ages of 11 and 17
Last Updated: April 12, 2012
Condition(s): Vaccines; Meningococcal Vaccines
2
Enrolling by invitation
Immunogenicity of Gardasil and Twinrix Vaccines Co-administered or Administered a Month Apart and the Effect of a Dose of Gardasil or Cervarix Administered 42 Months Later.
Last Updated: October 20, 2011
Condition(s): Human Papillomavirus
3
Completed
Human Papillomavirus (HPV) Registration Study (Gardasil)(V501-023)(COMPLETED)
Last Updated: November 18, 2010
Condition(s): Papillomavirus Infections
4
Active, not recruiting
A Study of Gardasil (V501) in Preadolescents and Adolescents (V501-018)
Last Updated: September 9, 2011
Condition(s): Healthy Papillomavirus Infections
5
Recruiting
A Phase I Trial of Safety and Immunogenicity of Gardasil(Registered Trademark) Vaccination Post Stem Cell Transplantation in Patients With and Without Immunosuppression
Last Updated: March 20, 2012
Condition(s): Gardasil Vaccine; Stem Cell Transplant; Immunogenicity; Quadrivalent HPC Vaccine; Healthy Volunteers
6
Completed
Study of an Investigational Vaccine in Pre-Adolescents and Adolescents (Gardasil)(V501-016)(COMPLETED)
Last Updated: May 20, 2011
Condition(s): Cervical Cancer; Genital Warts
7
Not yet recruiting
Immunogenicity and Safety of HPV Vaccine Gardasil in Young Women
Last Updated: November 5, 2008
Condition(s): Systemic Lupus Erythematosus
8
Active, not recruiting
GARDASIL™ Study in Healthy Females Between 9 and 26 Years of Age in Sub-Saharan Africa (V501-046)
Last Updated: April 11, 2012
Condition(s): Papillomavirus Infections
9
Completed
V501 Immunogenicity Study in Females Age 9 to 17 Years (V501-028)(COMPLETED)
Last Updated: May 13, 2011
Condition(s): HPV Infections
10
Completed
Immunogenicity to Human Papillomavirus Vaccine (Gardasil) Among IBD Patients on Immunosuppressive Therapy
Last Updated: May 3, 2011
Condition(s): Inflammatory Bowel Disease
11
Active, not recruiting
Cervical Intraepithelial Neoplasm (CIN) in Women (Gardasil)(V501-015)
Last Updated: January 4, 2012
Condition(s): Cervical Cancer; Genital Warts
12
Recruiting
Antibody Response to Human Papillomavirus Recombinant Vaccine (Gardasil®) in Girls and Young Women With Chronic Kidney Disease
Last Updated: May 25, 2010
Condition(s): Chronic Kidney Disease
13
Active, not recruiting
Post-Licensure Study of the Safety of GARDASIL™ in Males (V501-070 AM1)
Last Updated: April 17, 2012
Condition(s): Human Papilloma Virus Infection
14
Active, not recruiting
GARDASIL™ Vaccine Impact in Population Study
Last Updated: February 26, 2010
Condition(s): Human Papillomavirus Infections
15
Completed
An Immunogenicity and Safety Study of Gardasil® in Chinese Subjects (V501-030)(COMPLETED)
Last Updated: April 26, 2011
Condition(s): Papillomavirus Infections
16
Recruiting
Long Term Immunogenicity of Quadrivalent Human Papillomavirus Vaccine (Gardasil®)in HIV-infected Adolescents and Young Adults
Last Updated: January 18, 2012
Condition(s): HPV; HIV
17
Completed
Concomitant Use of Gardasil (V501) (Human Papillomavirus [Types 6, 11, 16, 18] Recombinant Vaccine) With Combined Diphtheria, Tetanus, Pertussis Vaccine and Meningococcal Conjugate Vaccine in Adolescents
Last Updated: April 14, 2010
Condition(s): Neoplasms, Glandular and Epithelial; Diphtheria; Tetanus; Whooping Cough; Meningitis
18
Completed
Observational Surveillance Study to Detect Potential Safety Signals in Patients Who Have Had at Least One Dose of GARDASIL™ (V501-031-AM2)(COMPLETED)
Last Updated: February 1, 2012
Condition(s): Human Papillomavirus Infection
19
Completed
Immunogenicity Bridge Between an Investigational Monovalent Vaccine and the Equivalent Component of Gardasil (V501) a Quadrivalent Vaccine (V501-012)(COMPLETED)
Last Updated: August 2, 2011
Condition(s): Cervical Cancer; Genital Warts
20
Active, not recruiting
Pilot Study to Determine the Safety and Efficacy of Gardasil Against the Human Papilloma Virus (HPV) in HIV-infected Men
Last Updated: March 12, 2012
Condition(s): Anal Cancer; HIV Infections

Clinical Trials content is provided directly by the U.S. National Institutes of Health via ClinicalTrials.gov and is not reviewed separately by ClinicalTrialsFeeds.org. Every page of specific clinical trials information contains a unique identifier which can be used to find further details directly from the National Institutes of Health.

The URL of this page is: http://clinicaltrialsfeeds.org/clinical-trials/results/?term=Gardasil

Page 1 of Clinical Trials for Gardasil, 102 Total Matches

Get the Latest Results via Email or RSS

Subscribe via Web Newsreaders

Browse

Clinical Trials Background

About